Presumably, the increase in the number of mitochondria in CD14+ monocytes may be a consequence of a compensatory mechanism that is necessary to maintain the reduced function of defective mitochondria in monocytes of patients with shorter duration of SSc. This evidence concerns the gene CD14 and systemic sclerosis.